Study Overview
Hall et al. (2021) investigated the dose-response relationship of creatine supplementation, examining how different dosing protocols affect intramuscular creatine concentrations and subsequent performance outcomes. The research sought to clarify whether higher doses produce proportionally greater benefits or whether a saturation ceiling limits the utility of excess supplementation (M & M, 2021) .
Key Findings
- Saturation ceiling confirmed: Muscle creatine stores have a finite capacity, typically around 150-160 mmol/kg dry muscle mass, beyond which additional creatine is simply excreted
- Loading vs. maintenance: A loading phase of 20g daily for 5-7 days achieves saturation in approximately one week, while 3-5g daily reaches the same endpoint in 3-4 weeks
- Body mass matters: Larger individuals may benefit from slightly higher maintenance doses (up to 5g) while smaller individuals may achieve saturation with 3g daily
- Diminishing returns at high doses: Doses exceeding 10g daily did not produce proportionally greater increases in muscle creatine content compared to standard 5g daily dosing
- Individual variation: Baseline dietary creatine intake and muscle fiber type composition influenced individual responses to supplementation
Practical Implications
This research supports the widely recommended 3-5g daily maintenance protocol as optimal for most individuals. The dose-response data suggests that more is not better when it comes to creatine supplementation. For those wanting fast results, a brief loading phase remains effective, but patient individuals can achieve the same outcome with consistent daily dosing at lower amounts. Body weight should be considered when selecting a specific dose within the 3-5g range — heavier individuals and those with greater muscle mass may benefit from the upper end of this range. Importantly, exceeding recommended doses wastes money and provides no additional performance or health benefits.
Study Limitations
- Individual genetic factors affecting creatine transport were not fully characterized
- The study focused primarily on skeletal muscle creatine, with limited data on brain or other tissue concentrations at different doses
- Dietary creatine intake from food sources was estimated rather than precisely measured in some participants
- Long-term dose-response data beyond several months was limited
Study Design and Methodology
Understanding how a study was designed helps assess the strength of its conclusions. Key methodological factors to evaluate include:
- Sample size — larger studies (n=50+) provide more reliable results than small studies (n=10-15). Small sample sizes increase the risk of false positives and limit the ability to detect moderate effect sizes
- Study duration — creatine research requires adequate duration for muscle saturation (minimum 4 weeks for maintenance dosing, 1 week for loading). Studies shorter than this may miss the full effect
- Blinding — double-blind, placebo-controlled designs (where neither researchers nor participants know who receives creatine) are the gold standard for minimising bias
- Population studied — results from trained athletes may not fully apply to untrained individuals, and vice versa. Age, sex, and dietary habits (particularly vegetarian status) also influence creatine response
- Outcome measures — direct measures (muscle biopsy, MRS imaging) are more informative than indirect proxies (blood markers, performance tests) for assessing creatine uptake and metabolism
Clinical Implications and Practical Relevance
This research contributes to our understanding of creatine in several practical ways:
For athletes and fitness enthusiasts: The findings support the use of creatine monohydrate as a safe, effective ergogenic aid. The standard dosing protocol of 3-5g daily remains well-supported by the cumulative evidence base including this study.
For healthcare professionals: Understanding the specific mechanisms and safety data from studies like this helps clinicians provide evidence-based guidance to patients who ask about creatine supplementation. The research consistently shows a favourable safety profile at recommended doses.
For the Malaysian context: While most creatine research is conducted in Western populations, the fundamental biochemistry (ATP-phosphocreatine system) is universal. Malaysian consumers can apply these findings with confidence, adjusting for local factors like tropical climate (increased hydration needs) and halal dietary requirements (synthetic creatine monohydrate is permissible).
How This Fits Into the Broader Evidence
No single study should be used to make definitive claims about creatine supplementation. Instead, this research should be viewed as one piece of a much larger evidence base:
- The ISSN Position Stand (2017) synthesises hundreds of studies into comprehensive recommendations
- Multiple systematic reviews and meta-analyses confirm creatine’s effects on strength, power, and lean mass
- Long-term safety data spanning up to 5 years shows no adverse effects at recommended doses
For a complete overview of the evidence, explore our Research Library which covers 60+ landmark creatine studies.
Sources & References
This page summarizes Hall et al. (2021). Full citation: Hall M, Trojian TH. Creatine supplementation. Current Sports Medicine Reports. 2021;20(9):482-492. doi:10.1249/JSR.0000000000000878
What This Means for You
For the average creatine user, this research supports the following practical recommendations:
- Choose creatine monohydrate — it remains the most studied and effective form
- Take 3-5g daily — consistent daily dosing is more important than timing
- Take it with food — insulin response from meals enhances muscle uptake
- Be patient — full saturation takes 3-4 weeks without loading
- Combine with exercise — creatine works best when paired with resistance or high-intensity training
For more on practical dosing strategies, see our creatine dosage guide.